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ABSTRACT 
Glucocorticoid hormones suppress the secretion of ACTH evoked 
by secretagogues such as CRF and arginine vasopressin. In this study, 
we investigated the effects of glucocorticoids on ACTH release induced 
by oxytocin (OT) and on intracellular free calcium ion levels in corti- 
cotropes prepared from the adenohypophyses of female Wistar rats. 
Pulsatile additions of physiological concentration of OT (10 nM) to 
superfused anterior pituitary cells caused pulsatile ACTH release about 
4-fold above basal secretion with similar peak amounts of ACTH during 
subsequent OT pulses. Exposure of the cells to corticosterone (100 nM) 
or to a selective glucocorticoid receptor agonist RU 28362 (100 nM) for 
30 min suppressed OT-stimulated but not basal ACTH release by 
approximately 60%. Inhibition gradually disappeared during subse- 
quent pulses of OT in the absence of corticosterone. Pretreatment with 
the selective antagonist RU 38486 (1 pM) completely blocked the 
inhibitory effect of corticosterone on OT-induced ACTH secretion. 
Changes in free cytosolic calcium levels in single cultured pituitary 
cells were measured using the calcium indicator Fura-2. OT caused 
calcium transients in corticotropes, which were identified by immuno- 
cytochemistry. They responded in a similar manner to a second OT 
stimulus when preincubated for 30 min with corticosterone (1 pM) or 
with RU 28362 (1 PM). Our data indicate that glucocorticoids, via 
glucocorticoid receptors, rapidly inhibit OT-stimulated ACTH secre- 
tion by corticotropes without affecting intracellular calcium transients 
due to OT. Therefore, we conclude that rapid inhibition of ACTH 
release by glucocorticoids interferes with cellular signal transduction 
beyond the step of calcium mobilization. (Endocrinology 132: 873-878, 
1993) 
I T IS well established that the secretion of ACTH by anterior pituitary corticotrope cells is stimulated by hypothalamic 
neurohormones, such as CRF or arginine vasopressin (AVP) 
(l), and is suppressed by adrenal glucocorticoid hormones 
(2). Several lines of evidence support the notion that oxytocin 
(OT) is involved in the regulation of pituitary ACTH secre- 
tion; it is present in high concentrations in rat hypophysial 
portal blood (3, 4), and high affinity receptors for OT have 
been identified in the rat pituitary (5). Recently, we have 
demonstrated that physiological concentrations of OT added 
in pulsatile fashion to isolated rat pituitary cells stimulate 
ACTH secretion, independent of other ACTH secretagogues 
(6). OT may therefore function as a hypophysiotropic hor- 
mone contributing to physiological regulation of ACTH re- 
lease by the hypothalamus. In addition, we showed that OT, 
like AVP and CRF, causes rises in free cytosolic calcium 
levels in corticotropes, suggesting that calcium transients play 
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the key role to trigger ACTH secretion (7-9). Indeed, studies 
with permeabilized cell preparations indicate that calcium is 
the main trigger substance in controlling exocytosis in exo- 
crine (10, 11) and endocrine cells (12-15), including a corti- 
cotropic tumor cell line (16). 
Glucocorticoid feedback inhibition of stimulated ACTH 
secretion comprises several time domains (17). Acute 
suppression is evident within less than one hour of gluco- 
corticoid administration, but the mechanism of the inhibitory 
action is unknown. In earlier studies (18-20) it was shown 
that a brief (20-40 min) exposure to corticosterone strongly 
inhibited ACTH secretion evoked by CRF or AVP. This 
inhibitory effect was fully antagonized by the glucocorticoid/ 
progestin-antagonist RU 38486, indicating that it is exerted 
through glucocorticoid receptors (21). 
There have been inconsistent reports using a mouse pitui- 
tary tumor cell line (AtT-20) regarding glucocorticoid effects 
on CRF-induced transients in intracellular calcium. In a 
recent study (22) it was reported that intracellular calcium 
signals due to CRF stimulation are suppressed by glucocor- 
ticoid hormones. But, using the same model, no change in 
intracellular calcium transients in the presence of glucocor- 
ticoids was recently reported (23). In order to understand the 
action of glucocorticoids on ACTH release and on intracel- 
lular calcium levels within normal pituitary corticotropes, we 
examined in the present study: 1) whether OT-induced 
ACTH secretion is inhibited by glucocorticoids; and 2) 
whether glucocorticoids modify transients in free cytosolic 
calcium levels triggered by OT. 
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Glucocorticoid hormones suppress the secretion of ACTH evoked 
by secretagogues such as CRF and arginine vasopressin. In this study, 
we investigated the effects of glucocorticoids on ACTH release induced 
by oxytocin (OT) and on intracellular free calcium ion levels in corti-
cotropes prepared from the adenohypophyses of female Wistar rats. 
Pulsatile additions of physiological concentration of OT (10 nM) to 
superfused anterior pituitary cells caused pulsatile ACTH release about 
4-fold above basal secretion with similar peak amounts of ACTH du ring 
subsequent OT pulses. Exposure of the cells to corticosterone (100 nM) 
or to a selective glucocorticoid receptor agonist RU 28362 (100 nM) for 
30 min suppressed OT-stimulated but not basal ACTH release by 
approximately 60%. Inhibition gradually disappeared during subse-
quent pulses of OT in the absence of corticosterone. Pretreatment with 
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the selective antagonist RU 38486 (1 /LM) completely blocked the 
inhibitory effect of corticosterone on OT-induced AC'1'H secretion. 
Changes in free cytosolic calcium levels in single cultured pituitary 
cells were measured using the calcium indicator Fura-2. 0'1' caused 
calcium transients in corticotropes, wh ich were identified by immuno-
cytoehemistry. They responded in a similar manner to a second 0'1' 
stimulus when preincubated for 30 min with corticosterone (1 /LM) or 
with RU 28362 (1 /LM). Our data indicate that glucocorticoids, via 
glucocorticoid receptors, rapidly inhibit O'1'-stimulated AC'1'H seere-
tion by corticotropes without affecting intracellular calcium transients 
due to OT. Therefore, we conclude that rapid inhibition of ACTH 
release by glucocorticoids interferes with cellular signal transduction 
beyond the step of calcium mobilization. (Endocrinology 132: 873-878, 
1993) 
the key role to trigger ACTH secretion (7-9). Indeed, studies 
with permeabilized ceIl preparations indicate that calcium is 
the main trigger substance in controlling exocytosis in exo-
crine (10, 11) and endocrine cells (12-15), including a corti-
cotropic tumor cellline (16). 
Glucocorticoid feedback inhibition of stimulated ACTH 
secretion comprises several time domains (17). Acute 
suppression is evident within less than one hour of gluco-
corticoid administration, but the mechanism of the inhibitory 
action is unknown. In earlier studies (18-20) it was shown 
that abrief (20-40 min) exposure to corticosterone strongly 
inhibited ACTH secretion evoked by CRF or AVP. This 
inhibitory effect was fully antagonized by the glucocorticoidj 
progestin-antagonist RU 38486, indicating that it is exerted 
through glucocorticoid receptors (21). 
There have been inconsistent re ports using a mouse pitui-
tary tumor cellline (AtT -20) regarding glucocorticoid effects 
on CRF-induced transients in intracellular calcium. In a 
recent study (22) it was reported that intracellular calcium 
signals due to CRF stimulation are suppressed by glucocor-
ticoid hormones. But, using the same model, no change in 
intracellular calcium transients in the presence of glucocor-
ticoids was recently reported (23). In order to understand the 
action of glucocorticoids on ACTH release and on intracel-
lular calcium levels within normal pituitary corticotropes, we 
examined in the present study: 1) whether OT-induced 
ACTH secretion is inhibited by glucocorticoids; and 2) 
whether glucocorticoids modify transients in free cytosolic 
calcium levels triggered by OT. 
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Materials and Methods 
Perifusion of isolated rat anterior pituitary cells 
The experimental procedures employed in this study have previously 
been described (21, 24) with necessary modifications (6). Briefly, dis- 
persed rat anterior pituitary cells were prepared by tryptic digestion 
from the adenohypophyses of female Wistar rats (250-350 g body wt; 
obtained from Charles River Wiga GmbH, Sulzfeld, Germany). The cells 
were mixed with preswollen Sephadex G-10 (Pharmacia, Uppsala, Swe- 
den) and transferred to perifusion columns (volume 0.4 ml) which were 
then perifused at 37 C with 22 rnM HEPES-buffered (pH 7.4) Dulbecco’s 
minimal essential medium (Flow Laboratories, Irvine, Scotland) contain- 
ing 0.25% (wt/vol) BSA (fraction V, Miles Laboratories, Elkhart, IN) and 
antibiotic-antimycotic drugs (Sigma, Deisenhofen, Germany). After an 
equilibration period of 2 h, various treatments were applied. OT was 
given every 30 min for a 5-min period. Glucocorticoid receptor agonists 
(corticosterone, RU 28362) were applied 25 min before the application 
of the second OT stimulus and were also included in the medium during 
the second exposure to OT. Glucocorticoid receptor antagonist (RU 
38486) was given 35 min before the second OT stimulus and was also 
present during exposure to corticosterone and OT. The synthetic steroids 
RU 28362, a selective glucocorticoid receptor agonist (25) and RU 38486, 
a glucocorticoid/progestin antagonist (26) were generously supplied by 
Roussel Uclaf (Romainville, France). Steroids were dissolved in dimeth- 
ylsulfoxide (DMSO; Sigma, Deisenhofen, Germany) and diluted in per- 
ifusion medium to the desired dilution. The final concentration of DMSO 
in the perifusion medium did not exceed 0.001%. 
Two-minute fractions of the column effluents were collected during 
the experimental period and assayed for ACTH content by RIA (27) 
using antiserum AS 6 (courtesy of G. B. Makara, Institute of Experimental 
Medicine, Hungarian Academy of Sciences, Budapest, Hungary). Puri- 
fied human ACTH1-39 (Sigma) was used as the standard. Data are 
reported as net ACTH release standardized within each cell column. 
The reference values taken as 100% are given in the figure legends. 
Data are expressed as the mean * SEM. Statistical evaluation was per- 
formed by two-way nonparametric analysis of variance, followed by 
Student’s two-tailed unpaired t test. 
Primary cultures of pituitary cells 
Pituitary cells were prepared as described previously (6). Aliquots of 
cell suspensions were plated in poly-t-lysine-coated plastic petri dishes 
with Dulbecco’s modified Eagle’s medium (Biochrom KG, Berlin, Ger- 
many) buffered with 26 rnM sodium bicarbonate, pH 7.0, containing 20 
rn~ cytosin-fl-o-arabino-furanoside and 10% fetal calf serum and incu- 
bated in a humidified atmosphere (5% C02/95% air) at 37 C for 3-5 
days. The medium was changed after 24 h and subsequently every 48 
h. 
Measurement of intracellular free calcium levels 
The procedures used to measure intracellular free calcium levels in 
single cells have been described (6). Briefly, the culture dish was washed 
with serum-free medium, and the cells were loaded with Fura-2/AM 
(Calbiochem, La Jolla, CA; 1.5 PM final concentration, 0.1% DMSO) for 
30 min at 37 C. The cells were then washed with modified Locke 
medium (140 rnM NaCl, 4.7 rnM KCl, 1 rnM CaCIZ, 1.2 rnM KHzP04, 1.2 
rn~ MgS04, 0.5 mM ascorbic acid, 11 mM glucose, 15 mM piperazine- 
N,N’-bis(2-ethanesulfonic acid), buffered to pH 7.2 with NaOH). The 
same medium was used for calcium measurements. The cells were then 
subjected to fluorescence measurements with a Zeiss microscope pho- 
tometer system (FFP, Zeiss, Oberkochen, Germany) up to 2 h after dye 
loading. The system is based on an inverted microscope (Axiovert 405M) 
equipped for epifluorescence, and interference filters of 340/10 nm and 
380/10 nm are alternatively mounted on the filter wheel. The ratio 
calculations r = F340/F380 were carried out according to Grynkiewicz 
et al. (28). 
Randomly selected cells from the culture dish were treated with an 
OT stimulus and recorded for 2 min. Responding cells were video 
printed. The cells were then washed twice and were incubated with 
corticosterone (1 FM) or RU 28362 (1 FM) for 25 min. The same cells 
were then subjected to a second OT stimulus in the presence of the 
steroid. After the calcium measurements, corticotropes were identified 
among the mixed cell population in the primary cultures by immuno- 
cytochemistry as described below. 
Immunocytochemistry of pituitary corticotropes in primary 
culture 
After the calcium measurements, the cells were fixed in cold para- 
formaldehyde (4% in 10 mM PBS, pH 7.2) for 30 min and incubated 
with anti-ACTH antiserum (courtesy of K. Kovacs, Institute of Experi- 
mental Medicine, Hungarian Academy of Sciences, Budapest, Hungary; 
final dilution 1:2000) overnight at 4 C. Antigen-antibody complexes 
were visualized by the double antibody avidin-biotin-peroxidase com- 
plex technique as described earlier (6). Antiserum specificity and method 
specificity were performed by omitting the primary antiserum and 
incubations with respective buffer or incubations with normal rabbit 
serum (1:2000). A coordinate system within the FFP allowed identifica- 
tion of cells previously analyzed for calcium transients. 
Results 
ACTH release by OT and inhibition by corticosterone 
The kinetics of ACTH release due to OT were first exam- 
ined with a concentration of the stimulating agent similar to 
that found in rat portal blood. Figure 1A shows the ACTH 
release by dispersed perifused rat anterior pituitary cells 
caused by five subsequent pulses of 10 nM OT. Successive 
applications of OT every 30 min for a 5-min period released 
similar amounts of ACTH up to 3 h. During the experimental 
period, basal ACTH release was approximately l-2% (15 + 
5 fmol/2-min fraction) of the total release and remained 
nearly constant throughout the experiment. 
Application of corticosterone at 100 nM for 25 min before 
and 5 min during the second OT stimulus suppressed ACTH 
release elicited by OT by approximately 60% (Fig. 1B). Basal 
ACTH release was not affected. The effect of corticosterone 
within this 30-min time domain was marked and statistically 
significant (P < 0.05). This effect of corticosterone was almost 
completely reversed within 180 min of subsequent OT ad- 
dition in the absence of further corticosterone application. 
Stimulation of ACTH release by higher doses of OT (10 FM) 
was inhibited by corticosterone (100 nM) to a similar extent 
as that observed with 10 nM OT. In these experiments, after 
exposure to corticosterone at 100 nM (similar experimental 
protocol as in Fig. 1B) the release of ACTH was inhibited by 
67% at the second OT stimulus and 48%, 27%, and 21% 
during subsequent pulses of OT (mean of two experiments). 
Furthermore, pituitary cells from primary cultures (4 days) 
were loaded into perifusion columns, and a similar cortico- 
sterone treatment as in Fig. 1 was applied. This experimental 
paradigm is important in order to compare the measurements 
of changes in intracellular calcium levels from primary cell 
cultures in the absence or presence of glucocorticoid hor- 
mones. Interestingly, we did not observe any difference in 
the net ACTH response due to OT (data not shown), and the 
inhibition by 100 nM corticosterone of OT-induced ACTH 
release was 35% at the second OT stimulus and 32%, 21%, 
and 7% during subsequent pulses of OT. 
Effect of glucocorticoid agonists and antagonists on OT-induced 
ACTH release 
The net ACTH release due to OT in the presence or 
absence of various glucocorticoids is shown in Figs. 2 and 3. 
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Data are expressed as the mean ± SEM. Statistical evaluation was per-
formed by two-way nonparametric analysis of variance, followed by 
Student's two-tailed unpaired t test. 
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Pituitary cells were prepared as described previously (6). Aliquots of 
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with Dulbecco's modified Eagle's medium (Biochrom KG, Berlin, Ger-
many) buffered with 26 mM sodium bicarbonate, pB 7.0, containing 20 
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N,N' -bis(2-ethanesulfonic acid), buffered to pB 7.2 with NaOB). The 
same medium was used for calcium measurements. The cells were then 
subjected to fluorescence measurements with a Zeiss microscope pho-
tometer system (FFP, Zeiss, Oberkochen, Germany) up to 2 h after dye 
loading. The system is based on an inverted mieroscope (Axiovert 405M) 
equipped for epifluorescence, and interference filters of 340/10 nm and 
380/10 nm are alternatively mounte  on the filter wheel. The ratio 
calculations r F340/F380 were carried out according to Grynkiewicz 
et al. (28). 
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Results 
ACTH release by OT and inhibition by corticosterone 
The kinetics of ACTH release due to OT were first exam-
ined with a concentration of the stimulating agent similar to 
that found in rat portal blood. Figure 1A shows the ACTH 
release by dispersed perifused rat anterior pituitary cells 
caused by five subsequent pulses of 10 nM OT. Successive 
applications of OT every 30 min for a 5-min period released 
similar amounts of ACTH up to 3 h, During the experimental 
period, basal ACTH release was approximately 1-2% (15 ± 
5 fmol/2-min fraction) of the total release and remained 
nearly constant throughout the experiment. 
Application of corticosterone at 100 nM for 25 min before 
and 5 min during the second OT stimulus suppressed ACTH 
release elicited by OT by approximately 60% (Fig. 18). Basal 
ACTH release was not affected. The effect of corticosterone 
within this 30-min time domain was marked and statistically 
significant (P < 0.05). This effect of corticosterone was almost 
completely reversed within 180 min of subsequent OT ad-
dition in the absence of further corticosterone application, 
Stimulation of ACTH release by high er doses of OT (10 /lM) 
was inhibited by corticosterone (100 nM) to a similar extent 
as that observed with 10 nM OT. In these experiments, after 
exposure to corticosterone at 100 nM (similar experimental 
protocol as in Fig. 1B) the release of ACTH was inhibited by 
67% at the second OT stimulus and 48%, 27%, and 21 % 
during subsequent pulses of OT (me an of two experiments). 
Furthermore, pituitary cells from primary cultures (4 days) 
were loaded into perifusion columns, and a similar cortico-
sterone treatment as in Fig. 1 was applied. This experimental 
paradigm is important in order to compare the measurements 
of changes in intracellular calcium levels from primary cell 
cultures in the absence or presence of glucocorticoid hor-
mones, Interestingly, we did not observe any difference in 
the net ACTH response due to OT (data not shown), and the 
inhibition by 100 nM corticosterone of OT-induced ACTH 
release was 35% at the second OT stimulus and 32%, 21 %, 
and 7% during subsequent pulses of OT. 
Effect of glucocorticoid agonists and antagonists on OT-induced 
ACTH release 
The net ACTH release due to OT in the presence or 
absence of various glucocorticoids is shown in Figs. 2 and 3. 
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FIG. 1. Release of ACTH by perifused 
rat anterior pituitary cells in response to 
subsequent pulses of 10 nM OT (A) and 
the effect of 100 nM corticosterone on 
this process (B). Perifused cells were ex- 
posed to 100 nM corticosterone for 25 
min as indicated by the bar (GC); the 
black bars show application of 10 nM OT 
for 5 min every 30 min. Data are ex- 
pressed as percentage of total amount of 
ACTH detected in all fractions assayed. 
The control experiment (A) represents 
the values from a single column run at 
the same time with other columns, where 
the cells were exposed to steroids simul- 
taneously. The points represent means, 
and the bars show SEM; n = 3. The effect 
of corticosterone (B) was significant (P 
< 0.05) 25 min, 60 min, and 90 min after 
steroid application. 
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FIG. 2. Effect of 100 nM corticosterone and antagonism by RU 38486 
(1 pM) on OT-induced ACTH release. Data are expressed as percentage 
of the net amount of ACTH release of the first control exposure to 10 
nM OT (range, 42-88 fmol/lO min). The points are means, and the bars 
show the SEM. RU 38486 was given 10 min before corticosterone 
application (arrow) and was also present during the 25 min of corticos- 
terone application (GC). The black bars show application of OT at 10 
nM for 5 min. Note that the data of the corticosterone experiment 
correspond to Fig. 1B. *, P < 0.05 when compared to control group (*). 
The glucocorticoid/progestin receptor antagonist RU 38486 
(1 FM) completely blocked the inhibitory action of corticos- 
terone (Fig. 2). In this experiment, RU 38486 was present 10 
min before and also included into the perifusion medium 
during the 25-min application of corticosterone before the 
second OT challenge. The corticosterone effect was antago- 
nized throughout the experimental period. 
In order to further characterize the glucocorticoid effect 
on OT-stimulated ACTH release, the cells were exposed for 
25 min to the highly selective glucocorticoid receptor agonist 
RU 28362 at a concentration of 100 nM. RU 28362 potently 
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FIG. 3. Effects of glucocorticoid agonist RU 28362 (100 nM) on ACTH 
release induced bv 10 nM OT. RU 28362 (GC) was present 25 min 
before and 5 minduring the second OT stimulus. The 100% value is 
the net ACTH release in response to the first OT stimulus applied 
(range, 40-90 fmol/lO min). The control experiment (+) was run with 
the same cell preparation. The glucocorticoid agonist effect was signif- 
icant (P < 0.05) at all following OT stimuli. The points are the means 
of three individual experiments; the bars show the SEM. 
suppressed OT-induced ACTH release by 80%, and this 
inhibition persisted for 2 h (Fig. 3). 
Transients in intracellular free calcium levels due to OT in the 
absence or presence of corticosterone or RU 28362 
Cytoplasmic calcium levels were analyzed in cultures from 
several different pituitary cell preparations and more than 
200 cells were investigated in this study. They were stimu- 
lated individually with 100 nM OT, and intracellular calcium 
levels were recorded for a 2-min period. The values given 
below represent data for OT-responsive and identified cor- 
ticotropes. 
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terone (Fig. 2). In this experiment, RU 38486 was present 10 
min be fore and also included into the perifusion medium 
during the 25-min application of corticosterone be fore the 
second OT challenge. The corticosterone effect was antago-
nized throughout the experimental period. 
In order to further characterize the glucocorticoid effect 
on OT -stimulated ACTH release, the cells were exposed for 
25 min to the highly selective glucocorticoid receptor agonist 
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the net ACTH release in response to the first OT stimulus applied 
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the same cell preparation. The glucocorticoid agonist effect was signif-
icant (P < 0.05) at all following OT stimuli. The points are the means 
of three individual experiments; the bars show the SEM. 
suppressed OT-induced ACTH release by 80%, and this 
inhibition persisted for 2 h (Fig. 3). 
Transients in intracellular {ree calcium levels due to OT in the 
absence or presence o{ corticosterone or RU 28362 
Cytoplasmic calcium levels were analyzed in cultures from 
several different pituitary cell preparations and more than 
200 cells were investigated in this study. They were stimu-
lated individually with 100 nM OT, and intracellular calcium 
levels were recorded for a 2-min period. The values given 
below represent data for OT -responsive and identified cor-
ticotropes. 
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In unstimulated corticotropes the basal calcium levels were 
stable and ranged from 70-100 nM (n = 21 corticotropes out 
of 225 examined cells). As already observed in our previous 
study (6), 100 nM OT increased the cytosolic free calcium 
concentrations in identified corticotropes (Figs. 4A and 5A). 
Figure 4B shows a representative calcium transient in 1 of 6 
immunocytochemically identified corticotropes, which was 
then incubated for 25 min with 1 FM corticosterone followed 
by a second 100 nM OT stimulus. In Fig. 5B, a similar 
experiment is shown using 1 PM RU 28362. Five identified 
corticotropes responded in the same way in the presence of 
the glucocorticoid agonist. Note that a similar protocol was 
followed in secretion studies where the cells were exposed 
to steroids for 25 min before and 5 min during OT stimula- 
tion. In all cells analyzed, the OT-induced intracellular cal- 
cium transients were not substantially different when the 
steroids were present. 
Discussion 
The regulation of adenohypophyseal ACTH secretion is 
complex and involves multiple regulatory factors of hypo- 
thalamic, neurohypophyseal, and peripheral origins. Among 
the stimuli that elicit ACTH from pituitary corticotropes are 
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FIG. 4. Rise of OT-induced intracellular calcium in a single immuno- 
cytochemically identified corticotrope in the absence or presence of 
corticosterone. Intracellular calcium concentration rapidly increases by 
a challenge with OT (100 nM) (A). After washing and preincubating 
the cells with 1 pM corticosterone for 25 min, the OT-responding cells 
were challenged with a second OT stimulus (B). Arrowheads indicate 
additions of OT. The profiles shown are representative of six cells 
treated in the same manner. 
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FIG. 5. Intracellular calcium levels in response to OT (100 nM) in the 
absence or presence of RU 28362. A similar experimental protocol was 
followed as described in Fig. 4. The glucocorticoid agonist RU 28362 (1 
/IM) was present 25 min before the second OT stimulus. Arrowheads 
indicate additions of OT. The profiles shown are representative of five 
cells treated in the same manner. 
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CRF and AVP (for review see Ref. 1). Recently, OT was 
shown to be an effective secretagogue of ACTH secretion: 
when applied in pulsatile fashion, it induces ACTH release 
by isolated pituitary corticotropes dose dependently and 
independent of the presence of CRF or AVP (6). An increase 
of intracellular calcium by mobilizing calcium mainly from 
intracellular stores appears to be the basic mechanism of OT 
action leading to ACTH secretion. 
As is generally accepted, increases in cytosolic free calcium 
result in the release of hormones or neurotransmitters by 
exocytosis (12-15, 29, 30). Such increase in intracellular 
calcium are brought about by calcium influx through the 
plasma membrane and/or release of calcium from intracel- 
lular stores (for review see Ref. 31). AVP causes the break- 
down of phosphoinositides and formation of inositol 1,4,5- 
trisphosphate (II’,) and diacylglycerol in dispersed rat ante- 
rior pituitary cells (32). IP3 causes an increase in cytosolic 
calcium by evoking its release from intracellular stores from 
many different types of cells including endocrine cells (33, 
34). Experimental evidence reported by different groups, that 
is secretion studies in the presence or absence of extracellular 
calcium or direct measurements of calcium transients in 
corticotropes exposed to OT or AVP (6,9,35,36), emphasizes 
the involvement of intracellular calcium stores during ACTH 
release. On the other hand, CRF causes influx of extracellular 
calcium through calcium channels, and these influxes are 
secondary to CRF-stimulated CAMP production (8, 37, 38). 
It has been proposed that calcium channels in a variety of 
cells are activated by CAMP (39, 40). A study with permea- 
bilized corticotrope tumor cells (AtT-20) provides evidence 
for requirement of calcium and no direct effect of CAMP on 
exocytotic release of ACTH (16). Thus, it can be concluded 
that intracellular calcium is the main regulatory substance, 
which triggers ACTH release from corticotropes irrespective 
of the secretagogues. However, as outlined above, the cal- 
cium sources are different: signal pathways for AVP and OT 
lead to mobilization of calcium mainly from intracellular 
stores, whereas CRF stimulation leads to calcium influx. 
It is well documented that inhibition of ACTH secretion is 
exerted by glucocorticosteroids from the adrenal cortex, 
which constitutes the negative feedback loop of the hypo- 
thalamo-pituitary-adrenocortical axis. Three types of time 
domains of the inhibitory action-rapid, delayed, and slow 
suppression-can be distinguished, and the rapid inhibitory 
action was proposed to be an effect on the secretory process 
(17). Although POMC gene down-regulation by glucocorti- 
coids has been observed within 15 min, an acute reversible 
change in the amounts of translated ACTH available for 
release in corticotropes is not likely (41, 42). The rapid 
inhibition by glucocorticoids of CRF- or AVP-induced ACTH 
release is well documented (18, 21, 43, 44). The present 
investigation demonstrates the rapid inhibition by glucocor- 
ticoids of OT-stimulated ACTH secretion. The time course 
(suppression is evident within 30 min) as well as the degree 
of inhibition (60%) is consistent with previous findings with 
other secretagogues (19, 45). The independence of rapid 
inhibition of the secretagogue used to stimulate ACTH re- 
lease and therefore of the intracellular pathways, which lead 
to elevation of cytosolic calcium, suggests a common mech- 
anism of the glucocorticoid effect. In addition, our results 
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s is generally accepted, increases in cytosolic free calcium 
result in the release of hormones or neurotransmitters by 
exocytosis (12-15, 29, 30). Such increase in intracellular 
calcium are brought about by calcium influx through the 
plasma membrane and/or release of calcium from intracel-
lular stores (for review see Ref. 31). AVP causes the break-
down of phosphoinositides and formation of inositol 1A,5-
trisphosphate (IP3) and diacylglycerol in dispersed rat ante-
rior pituitary cells (32). IP3 causes an increase in cytosolic 
calcium by evoking its release from intracellular stores from 
many different types of cells including endocrine cells (33, 
34). Experimental evidence reported by different groups, that 
is secretion studies in the presence or absence of extracellular 
calcium or direct measurements of calcium transients in 
corticotropes exposed to OT or A VP (6, 9, 35, 36), emphasizes 
the involvement of intracellular calcium stores during ACTH 
release. On the other hand, CRF causes influx of extracellular 
calcium through calcium channels, and these influxes are 
secondary to CRF-stimulated cAMP production (8, 37, 38). 
It has been proposed that calcium channels in a variety of 
cells are activated by cAMP (39, 40). A study with permea-
bilized corticotrope tumor cells (AtT -20) provides evidence 
for requirement of calcium and no direct effect of cAMP on 
exocytotic release of ACTH (16). Thus, it can be concluded 
that intracellular calcium is the main regulatory substance, 
which triggers ACTH release from corticotropes irrespective 
of the secretagogues. However, as outlined above, the cal-
cium sources are different: signal pathways for A VP and OT 
lead to mobilization of calcium mainly from intracellular 
stores, whereas CRF stimulation leads to calcium influx. 
It is weIl documented that inhibition of ACTH secretion is 
exerted by glucocorticosteroids from the adrenal cortex, 
which constitutes the negative feedback loop of the hypo-
thalamo-pituitary-adrenocortical axis. Three types of time 
domains of the inhibitory action-rapid, delayed, and slow 
suppression-can be distinguished, and the rapid inhibitory 
action was proposed to be an effect on the secretory process 
(17). Although POMC gene down-regulation by glucocorti-
coids has been observed within 15 mint an acute reversible 
change in the amounts of translated ACTH available for 
release in corticotropes is not likely (41, 42). The rapid 
inhibition by glucocorticoids of CRF- or AVP-induced ACTH 
release is weIl documented (18, 21, 43, 44). The present 
investigation demonstrates the rapid inhibition by glucocor-
ticoids of OT -stimulated ACTH secretion. The time course 
(suppression is evident within 30 min) as weIl as the degree 
of inhibition (60%) is consistent with previous findings with 
other secretagogues (19, 45). The independence of rapid 
inhibition of the secretagogue used to stimulate ACTH re-
lease and therefore of the intracellular pathways, which lead 
to elevation of cytosolic calcium, suggests a common mech-
anism of the glucocorticoid effect. In addition, our results 
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imply that rapid inhibition of OT-induced ACTH release by 
glucocorticoids, similar to the release induced by CRF or AVP 
in earlier studies (21), is mediated through glucocorticoid 
receptors. 
In contrast to a previous study (35), where 2 h dexameth- 
asone-pretreated adenohypophyseal cells were exposed to a 
single stimulus (10 min), we observed during pulsatile appli- 
cations of secretagogues a pronounced effect of glucocorti- 
coids on the peak of ACTH released. In addition, the short 
exposure (30 min) to corticosterone or glucocorticoid agonist 
and antagonist indicate the potency and specificity of the 
steroid effects on ACTH secretion due to pulsatile application 
of secretagogues. Such an experimental procedure is closer 
to conditions in vim, as evident from previous work dem- 
onstrating the rhythmic activity of oxytocinergic neurons in 
the paraventricular nucleus (46) and pulsatile release of OT 
into the circulation (47). 
However, the mechanism of rapid glucocorticoid inhibition 
on stimulated ACTH secretion is still unclear. In our previous 
study (6), we showed direct evidence that OT-induced ACTH 
secretion implies mobilization of calcium from intracellular 
stores. Our present results clearly demonstrate that the in- 
hibitory effect of glucocorticoid on OT-induced ACTH secre- 
tion is not exerted through changes in intracellular calcium 
levels, since neither glucocorticoid (corticosterone or RU 
28362) exhibits an effect on the OT-induced calcium tran- 
sients. In a previous study it was shown that AVP-induced 
calcium rise was also not altered by the presence of dexa- 
methasone from normal pituitary cell suspension (48). Since 
neither the kinetics of the OT-induced calcium transient 
onset nor the height of the peak were affected by the 
presence of glucocorticoids in the present study, we conclude 
that cytosolic calcium transients induced by OT are not 
affected by glucocorticoids, suggesting that glucocorticoids 
may not inhibit II’,-mediated calcium release from intracel- 
lular stores. Furthermore, IP3 production induced by phys- 
iological concentrations of AVP in anterior pituitary frag- 
ments is not inhibited by glucocorticoids within the rapid 
time domain (49, 50). These data suggest an effect of gluco- 
corticoids on a step further downstream in the stimulus- 
secretion coupling process, i.e. beyond stimulus-induced cal- 
cium mobilization from intracellular stores. 
The reports on glucocorticoid effects on CAMP production 
are controversial: An alteration of CRF-induced increases of 
CAMP levels by glucocorticoids was proposed (49, 51) and 
refuted (23, 52, 53). The latter studies, which support an 
effect of glucocorticoids beyond the rise of CAMP, are in 
accordance with secretion studies using permeable analogs 
of CAMP (20, 54). 
Studies using the clonal pituitary cell line AtT-20 also 
provide contradictory results regarding the glucocorticoid 
effect on CRF-induced intracellular calcium increase. A 
suppression of CRF-induced calcium transients was shown 
(22), whereas in another study no effect of glucocorticoids 
on intracellular calcium rise was found (23). A direct effect 
of glucocorticoids on stabilization of actin filaments was 
suggested as a possible mechanism (23). However, the slow 
time course for any rearrangement of the cytoskeleton (2 h) 
does not correspond to the rapid glucocorticoid inhibition of 
ACTH release by OT, CRF, and AVP reported in the present 
and previous studies (21, 44). 
Taken together, we provide direct evidence that OT-in- 
duced ACTH secretion is inhibited by glucocorticoids rapidly 
and that the immediate inhibitory action does not alter OT- 
induced calcium transients in corticotropes. We conclude that 
the inhibitory action on exocytotic ACTH release is mediated 
through glucocorticoid receptors and is exerted beyond the 
step of intracellular calcium increase. 
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